Pharma · Private company
Novo Nordisk A/S
Track this companyFree. Adds Novo Nordisk A/S to your Dealase workspace and tells you when its record changes.
Clinical trials2525 recruiting or active
Pipeline programs24From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline24
- CagrilintidePhase 3 · ObesityClinicalTrials.gov · fetched Nov 12, 2026
- CagrilintidePhase 3 · OverweightClinicalTrials.gov · fetched Nov 12, 2026
- CagrilintidePhase 3 · HypertensionClinicalTrials.gov · fetched Nov 12, 2026
- CagriSemaPhase 3 · HypertensionClinicalTrials.gov · fetched Nov 12, 2026
- CagriSema (Cagrilintide B and Semaglutide I)Phase 3 · Diabetes Mellitus, Type 2ClinicalTrials.gov · fetched Nov 12, 2026
- DenecimigPhase 3 · Haemophilia AClinicalTrials.gov · fetched Nov 12, 2026
- NNC0487-0111Phase 3 · ObesityClinicalTrials.gov · fetched Nov 12, 2026
- NNC0487-0111Phase 3 · Diabetes MellitusClinicalTrials.gov · fetched Nov 12, 2026
- NNC6019-0001Phase 3 · Transthyretin Amyloid Cardiomyopathy (ATTR CM)ClinicalTrials.gov · fetched Nov 12, 2026
- SemaglutidePhase 3 · Diabetes Mellitus, Type 2ClinicalTrials.gov · fetched Nov 12, 2026
- SemaglutidePhase 3 · ObesityClinicalTrials.gov · fetched Nov 12, 2026
- SemaglutidePhase 3 · HypertensionClinicalTrials.gov · fetched Nov 12, 2026
- SemaglutidePhase 3 · Non-alcoholic SteatohepatitisClinicalTrials.gov · fetched Nov 12, 2026
- ZenagamtidePhase 3 · Cardiovascular RiskClinicalTrials.gov · fetched Nov 12, 2026
- ZiltivekimabPhase 3 · Heart FailureClinicalTrials.gov · fetched Nov 12, 2026
- CDR132LPhase 2 · Heart FailureClinicalTrials.gov · fetched Nov 12, 2026
- Norditropin®Phase 2 · Short Stature Children Born Small for Gestational Age (SGA)ClinicalTrials.gov · fetched Nov 12, 2026
- SomapacitanPhase 2 · Short Stature Children Born Small for Gestational Age (SGA)ClinicalTrials.gov · fetched Nov 12, 2026
- UBT251Phase 2 · Diabetes Mellitus, Type 2ClinicalTrials.gov · fetched Nov 12, 2026
- NNC0642-1895Phase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- NNC4004-0002Phase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- SemaglutidePhase 1 · OverweightClinicalTrials.gov · fetched Nov 12, 2026
- TirzepatidePhase 1 · OverweightClinicalTrials.gov · fetched Nov 12, 2026
- ZenagamtidePhase 1 · OverweightClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials25
- GLP-1 Plus Lifestyle for Overall Wellness: Find Your Way ForwardPHASE4 · NOT_YET_RECRUITING · started Nov 15, 2026ClinicalTrials.gov NCT06977438 · fetched Nov 12, 2026
- A Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and ObesityPHASE3 · NOT_YET_RECRUITING · started Nov 11, 2026ClinicalTrials.gov NCT07919405 · fetched Nov 12, 2026
- A Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular Disease and Either Overweight or ObesityPHASE3 · NOT_YET_RECRUITING · started Oct 26, 2026ClinicalTrials.gov NCT07861100 · fetched Nov 12, 2026
- A Research Study Investigating Denecimig (Mim8) in Adults With Acquired Haemophilia APHASE3 · RECRUITING · started Oct 16, 2026ClinicalTrials.gov NCT07830732 · fetched Nov 12, 2026
- A Research Study Investigating How Adults With Overweight or Obesity, With or Without Type 2 Diabetes, Tolerate Switching to a New Treatment (Zenagamtide) From Their Current Tirzepatide MedicationPHASE1 · RECRUITING · started Oct 8, 2026ClinicalTrials.gov NCT07868354 · fetched Nov 12, 2026
- A Research Study Investigating How Adults With Overweight or Obesity, With or Without Type 2 Diabetes, Tolerate Switching to a New Treatment (Zenagamtide) From Their Current Semaglutide MedicationPHASE1 · RECRUITING · started Oct 5, 2026ClinicalTrials.gov NCT07855133 · fetched Nov 12, 2026
- A Study to See How Safe a New Medicine (NNC0642-1895) is in Healthy PeoplePHASE1 · RECRUITING · started Sep 17, 2026ClinicalTrials.gov NCT07829406 · fetched Nov 12, 2026
- A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 DiabetesPHASE3 · RECRUITING · started Aug 4, 2026ClinicalTrials.gov NCT07282613 · fetched Nov 12, 2026
- A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 DiabetesPHASE2 · RECRUITING · started Jun 22, 2026ClinicalTrials.gov NCT07668388 · fetched Nov 12, 2026
- Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse EventsPHASE1 · RECRUITING · started May 29, 2026ClinicalTrials.gov NCT07607587 · fetched Nov 12, 2026
- AMAZE 8: A Research Study Investigating How Well the Medicine NNC0487-0111 Compared to Semaglutide Helps People With Excess Body Weight and Type 2 Diabetes Lose WeightPHASE3 · ACTIVE_NOT_RECRUITING · started May 20, 2026ClinicalTrials.gov NCT07400107 · fetched Nov 12, 2026
- AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep ApnoeaPHASE3 · RECRUITING · started May 5, 2026ClinicalTrials.gov NCT07571109 · fetched Nov 12, 2026
- AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose WeightPHASE3 · ACTIVE_NOT_RECRUITING · started Apr 13, 2026ClinicalTrials.gov NCT07533175 · fetched Nov 12, 2026
- Weight Loss in People Living With Overweight or Obesity and Type 2 Diabetes Following Treatment With CagrilintidePHASE3 · ACTIVE_NOT_RECRUITING · started Nov 5, 2025ClinicalTrials.gov NCT07220759 · fetched Nov 12, 2026
- CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) AmyloidosisPHASE3 · RECRUITING · started Oct 2, 2025ClinicalTrials.gov NCT07207811 · fetched Nov 12, 2026
- A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular HypertrophyPHASE2 · RECRUITING · started Jun 27, 2025ClinicalTrials.gov NCT06979362 · fetched Nov 12, 2026
- Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2PHASE3 · RECRUITING · started May 6, 2025ClinicalTrials.gov NCT07227246 · fetched Nov 12, 2026
- A Research Study to Evaluate the Safety of NNC4004-0002 When Given to Participants With Asymptomatic HyperuricemiaPHASE1 · ACTIVE_NOT_RECRUITING · started Nov 13, 2024ClinicalTrials.gov NCT06859073 · fetched Nov 12, 2026
- A Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Participants With Heart Failure and InflammationPHASE3 · ACTIVE_NOT_RECRUITING · started Apr 1, 2024ClinicalTrials.gov NCT06200207 · fetched Nov 12, 2026
- A Research Study to Look at Long-term Treatment With a Medicine Called NNC6019-0001 for People Who Have Heart Failure Due to Transthyretin AmyloidosisPHASE2 · ACTIVE_NOT_RECRUITING · started Feb 20, 2024ClinicalTrials.gov NCT06260709 · fetched Nov 12, 2026
- A Research Study on How Well Semaglutide Helps Children and Teenagers With Excess Body Weight Lose WeightPHASE3 · ACTIVE_NOT_RECRUITING · started Jul 7, 2023ClinicalTrials.gov NCT05726227 · fetched Nov 12, 2026
- A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose WeightPHASE3 · ACTIVE_NOT_RECRUITING · started Nov 1, 2022ClinicalTrials.gov NCT05567796 · fetched Nov 12, 2026
- Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)PHASE3 · ACTIVE_NOT_RECRUITING · started Apr 1, 2021ClinicalTrials.gov NCT04822181 · fetched Nov 12, 2026
- A Research Study in Children Born Small and Who Stayed Small. Treatment is Somapacitan Once a Week Compared to Norditropin® Once a DayPHASE2 · ACTIVE_NOT_RECRUITING · started Jul 4, 2019ClinicalTrials.gov NCT03878446 · fetched Nov 12, 2026
- A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 DiabetesPHASE3 · ACTIVE_NOT_RECRUITING · started May 8, 2019ClinicalTrials.gov NCT03811561 · fetched Nov 12, 2026